Current status and future prospect of surgical treatment for pancreatic cancer.
作者信息
Yang Yinmo
机构信息
Department of General Surgery, Peking University First Hospital, Beijing 100034, China.
出版信息
Hepatobiliary Surg Nutr. 2020 Feb;9(1):89-91. doi: 10.21037/hbsn.2019.12.04.
Abstract
摘要
相似文献
1
Current status and future prospect of surgical treatment for pancreatic cancer.胰腺癌外科治疗的现状与未来展望
Hepatobiliary Surg Nutr. 2020 Feb;9(1):89-91. doi: 10.21037/hbsn.2019.12.04.
2
[Current status and future prospect of pharmacotherapy for pancreatic cancer].[胰腺癌药物治疗的现状与未来展望]
Zhongguo Zhong Yao Za Zhi. 2019 Apr;44(8):1509-1516. doi: 10.19540/j.cnki.cjcmm.20190104.002.
3
[Current status and prospect of the surgical treatment for pancreatic cancer].[胰腺癌外科治疗的现状与展望]
Nihon Shokakibyo Gakkai Zasshi. 2013 Dec;110(12):2066-72.
4
[Surgical management of pancreatic cancer: current practice and future prospect].[胰腺癌的外科治疗：当前实践与未来展望]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Oct;27(5):556-9.
5
[Current status and future prospect of pre- and post-operative adjuvant therapy of pancreatic cancer: discussion].[胰腺癌术前和术后辅助治疗的现状与未来展望：讨论]
Nihon Shokakibyo Gakkai Zasshi. 2011 Oct;108(10):1676-95.
6
[Application and prospect of artificial intelligence in pancreatic cancer].人工智能在胰腺癌中的应用与展望
Zhonghua Wai Ke Za Zhi. 2023 Jan 1;61(1):76-80. doi: 10.3760/cma.j.cn112139-20220419-00176.
7
Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer.胰腺癌靶向治疗和免疫治疗中的机遇与挑战。
Expert Rev Mol Med. 2021 Dec 15;23:e21. doi: 10.1017/erm.2021.26.
8
[Current status and future prospect of robot-assisted radical prostatectomy].机器人辅助根治性前列腺切除术的现状与未来展望
Nihon Rinsho. 2016 Jan;74(1):98-102.
9
[Management of head and neck cancer: current practice and future prospect].[头颈癌的管理：当前实践与未来展望]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Jun;28(3):311-4.
10
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).PROSPECT-CONKO 004研究的原理与设计：一项关于依诺肝素与化疗同步治疗胰腺癌的前瞻性随机试验。
BMC Cancer. 2008 Dec 5;8:361. doi: 10.1186/1471-2407-8-361.
引用本文的文献
1
Identification of exosome-related genes associated with prognosis and immune infiltration features in pancreatic cancer.胰腺癌中与预后及免疫浸润特征相关的外泌体相关基因的鉴定
Discov Oncol. 2025 Feb 17;16(1):192. doi: 10.1007/s12672-025-01961-1.
2
Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer.开发胰腺癌患者来源的3D生物打印模型。
J Adv Res. 2024 Sep 14. doi: 10.1016/j.jare.2024.09.011.
3
Laparoscopic radical distal pancreatectomy with portal venous tumor thrombectomy for the treatment of pancreatic acinar cell carcinoma after neoadjuvant chemotherapy.新辅助化疗后腹腔镜根治性远端胰腺切除术联合门静脉肿瘤血栓切除术治疗胰腺腺泡细胞癌
Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):991-996. doi: 10.21037/hbsn-23-395. Epub 2023 Nov 15.
4
Exosome and lipid metabolism-related genes in pancreatic adenocarcinoma: a prognosis analysis.胰腺腺癌中与外泌体和脂质代谢相关的基因：预后分析。
Aging (Albany NY). 2023 Oct 18;15(20):11331-11368. doi: 10.18632/aging.205130.
5
Revolutionizing preclinical research for pancreatic cancer: the potential of 3D bioprinting technology for personalized therapy.革新胰腺癌的临床前研究：3D生物打印技术在个性化治疗中的潜力
Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):616-618. doi: 10.21037/hbsn-23-248. Epub 2023 Jul 3.
6
The management strategy of pancreatic cancer in the era of systemic therapy-"Surgery First" or "Surgery Last"?全身治疗时代胰腺癌的管理策略——“手术优先”还是“手术最后”？
Hepatobiliary Surg Nutr. 2022 Aug;11(4):597-600. doi: 10.21037/hbsn-22-146.
7
Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasets.基于单细胞 RNA 测序和批量测序数据集的胰腺导管腺癌预后和诊断模型的开发和验证。
Hum Mol Genet. 2022 May 19;31(10):1705-1719. doi: 10.1093/hmg/ddab343.
8
Large-Section Histopathology Can Better Indicate the Immune Microenvironment and Predict the Prognosis of Pancreatic Ductal Adenocarcinoma Than Small-Section Histopathology.大体组织病理学比小组织病理学能更好地指示胰腺导管腺癌的免疫微环境并预测其预后。
Front Oncol. 2021 Jul 12;11:694933. doi: 10.3389/fonc.2021.694933. eCollection 2021.
9
Predicting early recurrence for resected pancreatic ductal adenocarcinoma: a multicenter retrospective study in China.预测切除术后胰腺导管腺癌的早期复发：一项中国多中心回顾性研究
Am J Cancer Res. 2021 Jun 15;11(6):3055-3069. eCollection 2021.
10
The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review.外泌体在胰腺癌中从基础研究到临床应用的作用：最新综述
Front Oncol. 2021 Feb 26;11:644358. doi: 10.3389/fonc.2021.644358. eCollection 2021.
本文引用的文献
1
Maintenance Olaparib for Germline -Mutated Metastatic Pancreatic Cancer.维持奥拉帕利治疗种系突变转移性胰腺癌。
N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2.
2
Whole genomes redefine the mutational landscape of pancreatic cancer.全基因组重新定义了胰腺癌的突变格局。
Nature. 2015 Feb 26;518(7540):495-501. doi: 10.1038/nature14169.
3
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.预计 2030 年美国癌症发病与死亡人数：甲状腺癌、肝癌和胰腺癌带来的意外负担。
Cancer Res. 2014 Jun 1;74(11):2913-21. doi: 10.1158/0008-5472.CAN-14-0155.
Zotero 插件